100016-62-4

Basic information

• Product Name: CALCITONIN, CHICKEN
• Synonyms: CALCITONIN, CHICKEN;H-CYS-ALA-SER-LEU-SER-THR-CYS-VAL-LEU-GLY-LYS-LEU-SER-GLN-GLU-LEU-HIS-LYS-LEU-GLN-THR-TYR-PRO-ARG-THR-ASP-VAL-GLY-ALA-GLY-THR-PRO-NH2;H-CYS-ALA-SER-LEU-SER-THR-CYS-VAL-LEU-GLY-LYS-LEU-SER-GLN-GLU-LEU-HIS-LYS-LEU-GLN-THR-TYR-PRO-ARG-THR-ASP-VAL-GLY-ALA-GLY-THR-PRO-NH2 (DISULFIDE BRIDGE: 1-7);CASLSTCVLGKLSQELHKLQTYPRTDVGAGTP-NH2;CASLSTCVLGKLSQELHKLQTYPRTDVGAGTP-NH2 (DISULFIDE BRIDGE: 1-7);Cys-Ala-Ser-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2 [Disulfide bridge: 1–7];Thyrocalcitonin from chicken
• CAS NO: 100016-62-4
• Molecular Formula: C145H240N42O46S2
• Molecular Weight: 3371.84
• Product Categories: Peptide
• Mol File: 100016-62-4.mol

Chemical Properties

• Appearance: /
• Density: 1.51±0.1 g/cm3(Predicted)
• Storage Temp.: -15°C
• CAS DataBase Reference: CALCITONIN, CHICKEN(CAS DataBase Reference)
• NIST Chemistry Reference: CALCITONIN, CHICKEN(100016-62-4)
• EPA Substance Registry System: CALCITONIN, CHICKEN(100016-62-4)

Safety Data

• Hazardous Substances Data: 100016-62-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Calcitonin, chicken is used as a therapeutic agent for the treatment of osteoporosis and other bone-related disorders. It helps in maintaining bone strength and density by inhibiting bone resorption and promoting calcium excretion, thereby reducing the risk of fractures and improving overall bone health.
Used in Research and Development:
Calcitonin, chicken serves as a valuable research tool for studying the physiological and pathological roles of calcitonin in humans. It aids in understanding the mechanisms of calcium regulation and bone metabolism, which can contribute to the development of novel treatments for bone diseases and other related conditions.
Used in Diagnostic Applications:
Calcitonin, chicken can be employed as a diagnostic marker for certain conditions, such as medullary thyroid carcinoma, where elevated levels of calcitonin in the blood can indicate the presence of the disease. This allows for early detection and timely intervention, improving patient outcomes.